MTN-004

A study evaluating the safety, acceptability and ease of use of the microbicide candidate VivaGel™ in sexually active, HIV-negative women ages 18 to 24.

See

Safety of new microbicide for HIV prevention to be tested in young women in U.S. trial

Jul 9, 2007

MTN-004 Backgrounder

MTN-004 Q&A

See Also

MTN-004 Study Protocol

Printer-friendly version

Microbicide Trials Network

MTN-004

News Room

Media Contact